Fully vaccinated COVID-19 patients with cancer had 13 per cent mortality rate: Study
Deccan ChronicleWashington: A new study evaluated the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicating that they remained at high risk for hospitalization and death. The study showed that fully vaccinated patients who experienced breakthrough infections had a hospitalization rate of 65 per cent, an ICU or mechanical ventilation rate of 19 per cent, and a 13 per cent death rate. "Patients with cancer who develop breakthrough COVID-19 even following full vaccination can still experience severe outcomes, including death," said Toni Choueiri, MD, director of the Lank Center for Genitourinary Care at Dana-Farber Cancer Institute and a senior author on the report. It's important to note that many of the same factors that we identified prior to the availability of vaccination -- age, comorbidities, performance status, and progressing cancer -- still seem to drive many of the bad outcomes," said Jeremy Warner, MD, director of the CCC19 Research Coordinating Center, associate professor at Vanderbilt-Ingram Cancer Center and a senior author of the study.